Loading...
XSHE
300595
Market cap1.39bUSD
Jul 10, Last price  
10.71CNY
1D
1.61%
1Q
-24.68%
IPO
-7.99%
Name

Autek China Inc

Chart & Performance

D1W1MN
XSHE:300595 chart
P/E
20.00
P/S
5.18
EPS
0.54
Div Yield, %
2.66%
Shrs. gr., 5y
1.07%
Rev. gr., 5y
16.27%
Revenues
1.85b
+2.00%
68,389,14991,010,663129,880,557176,236,651235,018,663311,629,074458,419,765646,903,715870,663,6011,295,045,8431,525,319,0721,737,168,4621,813,611,3241,849,823,367
Net income
480m
-16.20%
30,084,26424,800,00663,771,01288,704,851114,037,970150,858,706216,243,025306,889,260433,320,977554,737,177623,848,092666,599,820572,230,430479,524,593
CFO
827m
+20.80%
19,181,73053,374,81861,909,06280,232,430108,802,312144,709,478148,522,131275,365,341380,935,352630,094,069651,716,838723,384,236684,906,247827,381,484
Dividend
Nov 05, 20250.056 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Autek China Inc. focuses its operations on the entire process from conceptualization and development to the manufacturing and distribution of products related to ocular health and visual care. The company's offerings prominently feature specialized ophthalmic medical devices, including orthokeratology lenses, which are utilized for improving eyesight and managing the progression of short-sightedness. This enterprise was founded in 2001 and is primarily based in Hefei, China.
IPO date
Jan 17, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT